Cyclo Therapeutics, Inc.
CYTH · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $22,668 | $34,367 | $38,876 | $39,542 |
| - Cash | $928 | $1,122 | $2,995 | $9,247 |
| + Debt | $12,205 | $2,997 | $665 | $1,033 |
| Enterprise Value | $33,945 | $36,242 | $36,546 | $31,329 |
| Revenue | $234 | $123 | $202 | $311 |
| % Growth | 89.9% | -39.2% | -35% | – |
| Gross Profit | $217 | -$808 | -$634 | -$565 |
| % Margin | 92.8% | -656.4% | -313.2% | -181.5% |
| EBITDA | -$8,287 | -$5,634 | -$5,107 | -$5,638 |
| % Margin | -3,545% | -4,576.2% | -2,522.6% | -1,810.4% |
| Net Income | -$8,833 | -$5,981 | -$4,343 | -$5,642 |
| % Margin | -3,778.4% | -4,858.7% | -2,145.3% | -1,812% |
| EPS Diluted | -0.31 | -0.21 | -0.15 | -0.23 |
| % Growth | -47.6% | -40% | 34.8% | – |
| Operating Cash Flow | -$8,192 | -$3,848 | -$6,182 | -$4,295 |
| Capital Expenditures | -$3,848 | $3,848 | $0 | -$2 |
| Free Cash Flow | -$12,041 | -$3,848 | -$6,182 | -$4,297 |